Clinical trials · California
Clinical Stage III Esophageal Adenocarcinoma AJCC v8 clinical trials in California
We’re tracking 2 recruiting clinical stage iii esophageal adenocarcinoma ajcc v8 studies with a site in California — including Phase 2/Phase 3 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in California
- NCT06203600RecruitingPhase 2/Phase 3
Nivolumab plus standard treatment for advanced stomach or esophageal cancer
This trial tests whether adding the immunotherapy drug nivolumab to standard treatment works better for advanced stomach or esophageal cancer. It is for people whose cancer has already progressed after a first round of chemo plus immunotherapy.
Anaheim, CaliforniaAges 18 years+ - NCT05677490RecruitingPhase 3
Chemo options, with or without nivolumab, for HER2-negative stomach cancer
This Phase 3 trial compares two standard chemotherapy regimens for advanced stomach, esophagus, or gastroesophageal junction cancer that is HER2-negative. It also tests whether adding nivolumab (an immune therapy) improves outcomes.
Antioch, CaliforniaAges 18 years+
Clinical Stage III Esophageal Adenocarcinoma AJCC v8 trials by city in California
Where these studies are running in California
Institutions with a site for the recruiting clinical stage iii esophageal adenocarcinoma ajcc v8 studies listed above.
- Kaiser Permanente Dublin · 2 studies
- Kaiser Permanente Fremont · 2 studies
- Kaiser Permanente Fresno Medical Center · 2 studies
- Kaiser Permanente Medical Center - Santa Clara · 2 studies
- Kaiser Permanente Modesto Medical Center · 2 studies
- Kaiser Permanente Roseville Medical Center · 2 studies
- Kaiser Permanente Sacramento Medical Center · 2 studies
- Kaiser Permanente San Leandro · 2 studies
What taking part in a clinical stage iii esophageal adenocarcinoma ajcc v8 study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Clinical Stage III Esophageal Adenocarcinoma AJCC v8 trials in other states
Common questions
- Are there clinical stage iii esophageal adenocarcinoma ajcc v8 clinical trials in California?
- Yes. We're currently tracking 2 recruiting clinical stage iii esophageal adenocarcinoma ajcc v8 studies with a site in California, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a clinical stage iii esophageal adenocarcinoma ajcc v8 study in California?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in California to take part?
- Not necessarily. These studies have a site in California, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a clinical stage iii esophageal adenocarcinoma ajcc v8 trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New clinical stage iii esophageal adenocarcinoma ajcc v8 studies open in California regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.